BOK Financial’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $678K | Sell |
3,101
-286
| -8% | -$62.6K | 0.01% | 505 |
|
2025
Q1 | $758K | Buy |
3,387
+678
| +25% | +$152K | 0.01% | 473 |
|
2024
Q4 | $899K | Buy |
2,709
+301
| +13% | +$99.9K | 0.02% | 453 |
|
2024
Q3 | $716K | Sell |
2,408
-1,273
| -35% | -$378K | 0.01% | 496 |
|
2024
Q2 | $1.21M | Sell |
3,681
-265
| -7% | -$87.3K | 0.02% | 441 |
|
2024
Q1 | $1.56M | Buy |
3,946
+152
| +4% | +$60.2K | 0.03% | 415 |
|
2023
Q4 | $1.34M | Sell |
3,794
-255
| -6% | -$89.8K | 0.03% | 415 |
|
2023
Q3 | $1.29M | Sell |
4,049
-382
| -9% | -$122K | 0.03% | 396 |
|
2023
Q2 | $1.69M | Sell |
4,431
-38
| -0.9% | -$14.5K | 0.03% | 373 |
|
2023
Q1 | $1.55M | Buy |
4,469
+323
| +8% | +$112K | 0.03% | 391 |
|
2022
Q4 | $976K | Buy |
4,146
+2,511
| +154% | +$591K | 0.02% | 518 |
|
2022
Q3 | $402K | Sell |
1,635
-45
| -3% | -$11.1K | 0.01% | 705 |
|
2022
Q2 | $508K | Buy |
1,680
+126
| +8% | +$38.1K | 0.01% | 672 |
|
2022
Q1 | $639K | Sell |
1,554
-63
| -4% | -$25.9K | 0.01% | 685 |
|
2021
Q4 | $759K | Buy |
1,617
+57
| +4% | +$26.8K | 0.01% | 648 |
|
2021
Q3 | $662K | Buy |
+1,560
| New | +$662K | 0.01% | 669 |
|
2020
Q2 | – | Sell |
-1,749
| Closed | -$266K | – | 895 |
|
2020
Q1 | $266K | Sell |
1,749
-2
| -0.1% | -$304 | 0.01% | 712 |
|
2019
Q4 | $263K | Sell |
1,751
-362
| -17% | -$54.4K | 0.01% | 828 |
|
2019
Q3 | $300K | Sell |
2,113
-1,002
| -32% | -$142K | 0.01% | 783 |
|
2019
Q2 | $390K | Hold |
3,115
| – | – | 0.01% | 728 |
|
2019
Q1 | $343K | Sell |
3,115
-16,341
| -84% | -$1.8M | 0.01% | 757 |
|
2018
Q4 | $1.91M | Sell |
19,456
-22
| -0.1% | -$2.16K | 0.05% | 327 |
|
2018
Q3 | $2.41M | Buy |
19,478
+1,984
| +11% | +$245K | 0.06% | 334 |
|
2018
Q2 | $1.74M | Buy |
17,494
+13,846
| +380% | +$1.37M | 0.05% | 382 |
|
2018
Q1 | $322K | Sell |
3,648
-133
| -4% | -$11.7K | 0.01% | 755 |
|
2017
Q4 | $373K | Sell |
3,781
-24
| -0.6% | -$2.37K | 0.01% | 739 |
|
2017
Q3 | $367K | Sell |
3,805
-18
| -0.5% | -$1.74K | 0.01% | 738 |
|
2017
Q2 | $361K | Sell |
3,823
-1,004
| -21% | -$94.8K | 0.01% | 703 |
|
2017
Q1 | $394K | Sell |
4,827
-15
| -0.3% | -$1.22K | 0.01% | 700 |
|
2016
Q4 | $410K | Buy |
4,842
+206
| +4% | +$17.4K | 0.01% | 692 |
|
2016
Q3 | $346K | Sell |
4,636
-84
| -2% | -$6.27K | 0.01% | 725 |
|
2016
Q2 | $358K | Sell |
4,720
-615
| -12% | -$46.6K | 0.01% | 672 |
|
2016
Q1 | $370K | Buy |
+5,335
| New | +$370K | 0.01% | 648 |
|